Option chain shows key data for Ayurcann Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Ayurcann Holdings.

Ayurcann Holdings (OTC:AYURF) Stock, Option Chain

Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.

pexels-pixabay-47344

Cannabis

Earnings

News

AYURF

CSE:AYUR

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF), a Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announced on Thursday its first quarter financial and operational results for the three months ended Sept. 30, 2024. The Toronto-based company highlighted a 25% year-over-year increase in gross revenue, strong gross margin and top market presence in the vapes and pre-roll category in Ontario during the period.Ayurcann said fiscal 2024 and the beginning of fiscal 2025 was a pivotal time for Ayurcann and the broader cannabis industry in Canada.

Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

cannabis earnings, marijuana money

Marijuana Extraction Company Ayurcann Reports Record Gross Revenue For Fiscal Year 2024

merger, acquistion, business combination, deal

AOGO

Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity

AYURCANN HLDGS CORP by AYURCANN HLDGS CORP.

Ayurcann Holdings Corp

Press Releases

Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.

AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE

AYURCANN PROVIDES UPDATE ON BUSINESS COMBINATION

AYURCANN TERMINATES BUSINESS COMBINATION

AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE

AYURCANN REPORTS ANOTHER RECORD  SALES GROWTH IN Q2 2025 OF $13,363,509

AYURCANN REPORTS RECORD SALES GROWTH IN Q3 2025 OF $14,179,974 AND PROVIDES CORPORATE UPDATE

AOGOU

Ayurcann Holdings

Comments

Ayurcann Holdings

Ayurcann Holdings (AYURF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell